You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Awaiting product image

Article: P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool

€3.03

SKU: product-article-19001 Category: General

Description
Reviews (0)

Description

P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool

Reviews

There are no reviews yet.

Be the first to review “Article: P1.12 Tumor lysis syndrome: monocentric evaluation of a predictive tool”

You must be logged in to post a review.

Top